Display options
Share it on

J Bone Jt Infect. 2021 May 27;6(6):203-205. doi: 10.5194/jbji-6-203-2021. eCollection 2021.

Reply to McNally's comment on "Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience" by Steinhausen et al. (2021).

Journal of bone and joint infection

Eva Steinhausen, Rolf Lefering, Martin Glombitza, Nikolaus Brinkmann, Carsten Vogel, Bastian Mester, Marcel Dudda

Affiliations

  1. Department of Orthopedic and Trauma Surgery, BG Klinikum Duisburg, University of Duisburg-Essen, 47249 Duisburg, Germany.
  2. Department of Trauma, Hand and Reconstructive Surgery, University Hospital Essen, University of Duisburg Essen, Essen, Germany.
  3. Institute for Research in Operative Medicine (IFOM), University of Witten/Herdecke, Cologne, Germany.

PMID: 34123710 PMCID: PMC8188879 DOI: 10.5194/jbji-6-203-2021

[No abstract available.]

Conflict of interest statement

Martin Glombitza declares that he signed a consultant contract with BonAlive in May 2017.

References

  1. Bone Joint J. 2015 Jun;97-B(6):814-7 - PubMed
  2. J Bone Jt Infect. 2021 Jan 12;6(4):73-83 - PubMed
  3. Z Orthop Unfall. 2018 Apr;156(2):152-159 - PubMed
  4. J Bone Jt Infect. 2021 May 27;6(6):199-201 - PubMed
  5. J Orthop. 2019 Aug 13;17:173-179 - PubMed
  6. Bone Joint J. 2014 Jun;96-B(6):845-50 - PubMed
  7. J Bone Jt Infect. 2019 Dec 10;4(6):306-313 - PubMed
  8. Adv Exp Med Biol. 2017;971:81-92 - PubMed
  9. Infection. 2020 Jun;48(3):333-344 - PubMed
  10. Biomed Res Int. 2016;2016:6984656 - PubMed

Publication Types